biotechnology

EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial

September 9, 2026

EpilepsyGTx, a biotechnology company developing gene therapies for refractory epilepsy, and Viralgen, a leading contract development and manufacturing…

HHealth

An aerial shot of a salmon farm in Scotland.

September 4, 2026

Research led by PhD researcher Alexander Dindial alongside professor James Bron and Dr Sean Monaghan at the University’s…

HHealthcare

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push

August 31, 2026

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…

BBusiness

Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy

August 31, 2026

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…

HHealth

Paternal sperm epigenetics may help explain early pregnancy loss

August 29, 2026

When a pregnancy ends early and unexplained, the search for answers usually begins with the mother. Lacey Luense,…

HHealthcare

FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment

August 28, 2026

Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…

HHealth

Compact bNIRS technology could become a diagnostic toolkit for dementia

August 27, 2026

Brain diseases, including dementia, have long been studied using experimental animals such as mice. However, differences between the…

HHealthcare

HHS plans new FDA leadership roles for technology, drugs

August 25, 2026

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health…

MMental health

A scoping review on the mental health harms of LLM-based chatbots

August 22, 2026

Weizenbaum, J. ELIZA—a computer program for the study of natural language communication between man and machine. Commun. ACM…

SScience

Arugula nanovesicles counteract diet-induced obesity and modulate gut inflammation and microbiota in vivo

August 20, 2026

Competing interests The authors declare no conflicts of interest, except for C.L. for the patent WO 2024/223549 A1,…

MMedication

Amylyx endocrine drug succeeds in key study for low blood sugar

August 18, 2026

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…

HHealthcare

August 12, 2026

Together, the two companies give physicians a single platform to measure biological insights, deliver personalized interventions, and demonstrate…

EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial

Stirling team develops new method to study salmon lice secretions

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push

Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy

Paternal sperm epigenetics may help explain early pregnancy loss

Brain organoids reveal how Alu-mediated gene deletion can lead to neurodegeneration

A scoping review on the mental health harms of LLM-based chatbots

Arugula nanovesicles counteract diet-induced obesity and modulate gut inflammation and microbiota in vivo

Amylyx endocrine drug succeeds in key study for low blood sugar

Viome Acquires Circulate Health, Closing the Loop Between Early Diagnostics, Precision Nutrition, and Treatment